Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Landerlan SA
Original Assignee
Laboratorios Landerlan SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Landerlan SAfiledCriticalLaboratorios Landerlan SA
Priority to ES535617ApriorityCriticalpatent/ES8604744A1/en
Publication of ES535617A0publicationCriticalpatent/ES535617A0/en
Publication of ES8604744A1publicationCriticalpatent/ES8604744A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Abstract
Anti-thrombin (III) is prepared from human plasma from which the cryo-precipitate and pro-thrombotic complex has been previously separated, by (a) extracting semi-purified anti-thrombin III with aluminium hydroxide gel; (b) pasteurising for 10 hours at 60 deg.C in presence of 0.5 M citrate of pH 8.3; and
ES535617A1984-09-031984-09-03Anti-thrombin III prepn.
ExpiredES8604744A1
(en)